These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6110107)

  • 1. Coronary heart disease, fibrinogen, and plasma heparin neutralising activity.
    O'Brien JR; Etherington MD
    Lancet; 1981 Feb; 1(8218):495-6. PubMed ID: 6110107
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin effect on plasma fibrinogen in the thrombophilic syndrome.
    Singer A
    Clin Cardiol; 1986 Apr; 9(4):A18. PubMed ID: 3720040
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose intermittent heparin therapy decreases plasma fibrinogen levels.
    Engelberg H
    Semin Thromb Hemost; 1991; 17 Suppl 2():219-23. PubMed ID: 1948093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin resistance and plasma fibrinogen in elderly subjects with and without occlusive vascular disease.
    Cotton RC; Shaikh MS; Dent RV
    J Atheroscler Res; 1968; 8(6):959-66. PubMed ID: 5707801
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study.
    Baker IA; Eastham R; Elwood PC; Etherington M; O'Brien JR; Sweetnam PM
    Br Heart J; 1982 May; 47(5):490-4. PubMed ID: 7073911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state.
    Patrassi GM; Toffanin F; Massa G; Schivazappa L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):414-25. PubMed ID: 89993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hypolipidemic agents on the content of sterol-fibrinogen complexes of the blood in patients with ischemic heart disease].
    Palamarchuk VI; Fedorishko SS
    Vrach Delo; 1989 Jan; (1):39-41. PubMed ID: 2718441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of blood coagulation by heparin and related proteins].
    Takahashi K; Niwa M; Yamagishi R; Sakuragawa N
    Rinsho Ketsueki; 1987 Jul; 28(7):1094-101. PubMed ID: 3694818
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin-releasable platelet factor 4 in patients with coronary artery disease.
    Cella G; Luzzatto G; Strauss WE
    Clin Cardiol; 1992 Jan; 15(1):4. PubMed ID: 1541073
    [No Abstract]   [Full Text] [Related]  

  • 10. The prothrombotic potential of platelet factor 4.
    Thachil J
    Eur J Intern Med; 2010 Apr; 21(2):79-83. PubMed ID: 20206875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of plasma fibrinogen in coronary artery disease.
    Meade TW
    Int J Cardiol; 1992 Dec; 37(3):424-6. PubMed ID: 1468831
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.
    Lee AJ; Lowe GD; Woodward M; Tunstall-Pedoe H
    Br Heart J; 1993 Apr; 69(4):338-42. PubMed ID: 8489866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the coagulograms of patients with coronary insufficiency according to the age group].
    Gurevich MA; Levantovskaia OM
    Kardiologiia; 1968 Sep; 8(9):78-83. PubMed ID: 5728510
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen, coronary heart disease and prospective studies.
    Pickart L
    Lancet; 1981 Feb; 1(8218):495. PubMed ID: 6110106
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fluctuations in lipid levels and state of the blood coagulation system in ischemic heart disease].
    Ganelina IE; Deriagina GP; Krivoruchenko IV; Ryvkin BA
    Kardiologiia; 1972 Jan; 12(1):38-45. PubMed ID: 5016705
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting.
    Neumann FJ; Gawaz M; Ott I; May A; Mössmer G; Schömig A
    J Am Coll Cardiol; 1996 Jan; 27(1):15-21. PubMed ID: 8522689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fibrinogen and coronary heart disease in urban Japanese.
    Sato S; Nakamura M; Iida M; Naito Y; Kitamura A; Okamura T; Nakagawa Y; Imano H; Kiyama M; Iso H; Shimamoto T; Komachi Y
    Am J Epidemiol; 2000 Sep; 152(5):420-3. PubMed ID: 10981454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fibrinogen patterns in patients with coronary atherosclerosis.
    Hampton JW; Mantooth J; Brandt EN; Wolf SG
    Circulation; 1966 Dec; 34(6):1098-101. PubMed ID: 5928554
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
    Timmis GC; Mammen EF; Ramos RG; Gordon S; Gangadharan V; Hauser AM; Westveer DC; Stewart JR
    Arch Intern Med; 1986 Apr; 146(4):667-72. PubMed ID: 3963947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood coagulation and fibrinolytic system in patients with marked coronary arteriosclerosis].
    Gritsiuk AI; Sopina NV
    Kardiologiia; 1970 Oct; 10(10):9-16. PubMed ID: 4251295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.